Appendix removal linked to lower risk of colon cancer, study finds
Patients who had their inflamed appendix removed were less likely to develop colorectal cancer than those treated only with antibiotics, a new study shows.
A new study reveals that patients who undergo surgery to remove an inflamed appendix appear to have a lower risk of developing colorectal cancer compared to those treated with antibiotics alone. The research, presented at the American College of Surgeons Clinical Congress in Washington, analyzed data from 15,774 patients who underwent the procedure and 15,295 patients who received antibiotics.
The findings indicate that 0.7% of the surgical group developed colorectal cancer, while 1.7% of the antibiotic-treated group did. This translates to a 58% reduction in cancer risk for those who had their appendix removed, taking into account individual risk factors. Dr. Valentin Nfonsam, a researcher from Morehouse School of Medicine in Atlanta, suggests that the appendix may play a role in the immune system and gut microbiome, challenging previous assumptions that it served no purpose.
However, he clarifies that the study does not definitively prove that appendix removal prevents cancer. Moreover, he stresses that antibiotic treatment remains a crucial option and advocates for further research to unravel the potential connection between ongoing inflammation, microbiome changes, and cancer risk.
Written by urgent.news from Ajel English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
